<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.regulatory.v2.soap.GetRegulatorySnapshotOutput xmlns:ns2="local" id="279374"><Title>Biologics License Application (supplemental BLA) 125510/106: FLUAD (influenza vaccine, adjuvanted) Suspension for Injection – Approval Package, 13-Jul-2018</Title><Versions><Version>None</Version></Versions><Status>Valid</Status><Abstract>This supplemental biologics license application, BLA 125510/106, provided to include the 2018-2019 United States formulation and associated labeling revisions. FLUAD is a combination product, as per 21 CFR 3.2(e).&lt;br/&gt;&lt;br/&gt;Name: FLUAD&lt;br/&gt;Active ingredient(s): influenza vaccine, adjuvanted&lt;br/&gt;Company: Seqirus, Inc.&lt;br/&gt;Indication(s): It is indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.&lt;br/&gt;Pharmaco-therapeutic group - (ATC code): Vaccines, Influenza vaccines - (J07BB02)&lt;br/&gt;Dosage form: Suspension for Injection &lt;br/&gt;Packaging: Pre-filled syringe&lt;br/&gt;Route of administration: Intramuscular use&lt;br/&gt;Review classification/review pathway: Standard review drug</Abstract><Comment>This document has been revised to include Labeling of FLUAD (influenza vaccine, adjuvanted).

This document contains the Approval Letter and Labeling. 

N.B.: This exclusive document has been prepared by integrating the files released by the FDA into one comprehensive document. It is also enriched with cover pages and a detailed Table of Contents provided in the left frame.</Comment><Region>USA</Region><Languages><language>English</language></Languages><Number>279374</Number><DocCategories><DocCategory>Reference Document</DocCategory></DocCategories><ProdCategories><ProdCategory>Drugs and Biologics</ProdCategory><ProdCategory>Medical Devices and IVDs</ProdCategory></ProdCategories><DocTypes><DocType>Approval Package</DocType><DocType>BLA</DocType><DocType>Product Approval Document</DocType><DocType>Supplemental Approval</DocType></DocTypes><Source>http://www.fda.gov/&lt;br/&gt;06-SEP-2018</Source><DateDisplay>13-Jul-2018</DateDisplay><DocForm>0</DocForm><AddedDate>17-Jul-2018</AddedDate><LastUpdatedDate>06-Sep-2018 05:52:00</LastUpdatedDate><Topics><Topic>Packaging and Labelling</Topic></Topics><MedicalDeviceSpecialties></MedicalDeviceSpecialties></ns2:com.thomsonreuters.ls.service.contract.regulatory.v2.soap.GetRegulatorySnapshotOutput>